{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:57:29Z","timestamp":1793249849831,"version":"4.5.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Exposure to\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (\n                    <jats:italic>Mtb<\/jats:italic>\n                    ) leads to a spectrum of outcomes, from latent infection to active disease, but limited insight into protective immune correlates has hampered vaccine development. Using a proteome-wide\n                    <jats:italic>Mtb<\/jats:italic>\n                    microarray, we mapped antibody specificities across individuals with varying\n                    <jats:italic>Mtb<\/jats:italic>\n                    exposure, including humans with controlled latent tuberculosis infection, uncontrolled active TB, or that resist IGRA conversion as well as non-human primates with near sterilized\n                    <jats:italic>Mtb<\/jats:italic>\n                    infection following intravenous BCG. While current TB vaccine antigens were poorly immunogenic across most populations, striking overlap in antibody binding was observed to surface and secreted proteins, all associated with enhanced antibody functions and some also robustly targeted by T cells. Collectively, these data provide an atlas of antibody protein binding across the spectrum of Mtb infection, and further point to a handful of promising Mtb protein candidates to guide the design of antibody-based TB interventions aimed at mitigating disease globally.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1810894","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:49:47Z","timestamp":1780462187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A proteome-wide atlas of humoral immunity to Mycobacterium tuberculosis across the spectrum of disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Mehak Z.","family":"Khan","sequence":"first","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Irvine","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Cizmeci","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]},{"name":"Department of Biological Engineering, Massachusetts Institute of Technology","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela R. L.","family":"Davies","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlo Z.","family":"Randall","sequence":"additional","affiliation":[{"name":"Antigen Discovery Inc.","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozelyn","family":"Pablo","sequence":"additional","affiliation":[{"name":"Antigen Discovery Inc.","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Vidal","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center and Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninaad","family":"Lasrado","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center and Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Darrah","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health","place":["Bethesda, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff C.","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]},{"name":"Department of Biological Engineering, Massachusetts Institute of Technology","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Mann","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Nair","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia S.","family":"Grace","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fontana","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Juelg","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan H.","family":"Barouch","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center and Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca I.","family":"Restrepo","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Texas Health Science Center at Houston","place":["Brownsville, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roederer","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health","place":["Bethesda, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Seder","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health","place":["Bethesda, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Wallis","sequence":"additional","affiliation":[{"name":"The Aurum Institute","place":["Johannesburg, South Africa"]},{"name":"Department of Medicine, Division of Infectious Diseases, School of Public Health, University of the Witwatersrand","place":["Johannesburg, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Churchyard","sequence":"additional","affiliation":[{"name":"The Aurum Institute","place":["Johannesburg, South Africa"]},{"name":"Department of Medicine, Division of Infectious Diseases, School of Public Health, University of the Witwatersrand","place":["Johannesburg, South Africa"]},{"name":"Department of Medicine, Vanderbilt University","place":["Nashville, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University","place":["Cleveland, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Henry","family":"Boom","sequence":"additional","affiliation":[{"name":"Department of Medicine, Case Western Reserve University","place":["Cleveland, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Campo","sequence":"additional","affiliation":[{"name":"Antigen Discovery Inc.","place":["Irvine, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Fortune","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[{"name":"Ragon Institute of MGH, MIT and Harvard","place":["Cambridge, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","article-title":"Global tuberculosis report","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B3","first-page":"39","article-title":"Prevalence of latent tuberculosis infection among gold miners in South Africa","volume":"13","author":"Hanifa","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy751","article-title":"Long-term stability of resistance to latent Mycobacterium tuberculosis infection in highly exposed tuberculosis household contacts in Kampala, Uganda","volume":"68","author":"Stein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx380","article-title":"Resistance and susceptibility to Mycobacterium tuberculosis infection and disease in tuberculosis households in Kampala, Uganda","volume":"187","author":"Stein","year":"2018","journal-title":"Am J Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-33-4-941","article-title":"Tuberculosis in student nurses and medical students at the University of Wisconsin","volume":"33","author":"Dickie","year":"1950","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1128\/9781683670261.ch9","article-title":"IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.8.4204","article-title":"Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice","volume":"97","author":"Sousa","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.9.5407","article-title":"Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis","volume":"162","author":"Caruso","year":"1999","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomized, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16076","DOI":"10.1016\/s0140-6736(25)00516-1","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1128\/cmr.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01777-9","article-title":"Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis","volume":"9","author":"Irvine","year":"2024","journal-title":"Nat Microbiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00996","article-title":"A case for antibodies as mechanistic correlates of immunity in tuberculosis","volume":"10","author":"Kawahara","year":"2019","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.05.004","article-title":"Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction","volume":"58","author":"Grace","year":"2025","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41541-023-00735-6","article-title":"Author correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis","volume":"8","author":"Krishnananthasivam","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167960","article-title":"Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan","volume":"8","author":"Liu","year":"2023","journal-title":"JCI Insight"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00198-10","article-title":"Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value","volume":"17","author":"Ireton","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856906","article-title":"Defining discriminatory antibody fingerprints in active and latent tuberculosis","volume":"13","author":"Nziza","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/infdis\/jis421","article-title":"Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients","volume":"206","author":"Kunnath-Velayudhan","year":"2012","journal-title":"J Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009080107","article-title":"Dynamic antibody responses to the Mycobacterium tuberculosis proteome","volume":"107","author":"Kunnath-Velayudhan","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401849","article-title":"IgH chain class switch recombination: mechanism and regulation","volume":"193","author":"Stavnezer","year":"2014","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2471\/blt.10.085738","article-title":"Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases","volume":"89","author":"Restrepo","year":"2011","journal-title":"Bull World Health Organ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix023","article-title":"Diagnostic performance of tuberculosis-specific IgG antibody profiles in patients with presumptive tuberculosis from two continents","volume":"64","author":"Broger","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.05304-11","article-title":"Plasma antibody profiles as diagnostic biomarkers for tuberculosis","volume":"18","author":"Khan","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1039\/c8an00599k","article-title":"Partial least squares-discriminant analysis (PLS-DA) for classification of high-dimensional (HD) data: a review of contemporary practice strategies and knowledge gaps","volume":"143","author":"Lee","year":"2018","journal-title":"Analyst"},{"key":"B33","doi-asserted-by":"publisher","first-page":"060012","DOI":"10.1101\/060012","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/jci140073","article-title":"Monocyte metabolic transcriptional programs associate with resistance to tuberculin skin test\/interferon-gamma release assay conversion","volume":"131","author":"Simmons","year":"2021","journal-title":"J Clin Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.13191.3","article-title":"Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa [version 3; peer review: 1 approved","volume":"5","author":"Ntshiqa","year":"2022","journal-title":"Gates Open Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu320","article-title":"Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy","volume":"181","author":"Vynnycky","year":"2015","journal-title":"Am J Epidemiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1214289","article-title":"A trial of mass isoniazid preventive therapy for tuberculosis control","volume":"370","author":"Churchyard","year":"2014","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/bf00381781","article-title":"Characterization of the highly abundant polymorphic GC-rich-repetitive sequence (PGRS) present in Mycobacterium tuberculosis","volume":"163","author":"Poulet","year":"1995","journal-title":"Arch Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00969-16","article-title":"The enigmatic PE\/PPE multigene family of mycobacteria and tuberculosis vaccination","volume":"85","author":"Brennan","year":"2017","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01066-1","article-title":"Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques","volume":"22","author":"Irvine","year":"2021","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2024.10.001","article-title":"Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Syst"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci128459","article-title":"Capsular glycan recognition provides antibody-mediated immunity against tuberculosis","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41467-021-20930-0","article-title":"Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis","volume":"12","author":"Watson","year":"2021","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.194.supp.73.4","article-title":"Safety and immunogenicity of the Ad35\/AERAS-402 tuberculosis vaccine in a phase 2 dose-finding clinical trial in BCG-vaccinated healthy infants (VAC5P.1119)","volume":"194","author":"Hokey","year":"2015","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13063-017-2354-0","article-title":"A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1\/IC31(R) in people living in a TB-endemic area","volume":"19","author":"Hussein","year":"2018","journal-title":"Trials"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100313","article-title":"A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa","volume":"21","author":"Bekker","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(20)30319-2","article-title":"Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomized, double-blind, placebo-controlled, phase 2a trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040652","article-title":"Safety and immunogenicity of the gamTBvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study","volume":"8","author":"Tkachuk","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy312","article-title":"Human experimental challenge with enterotoxigenic escherichia coli elicits immune responses to canonical and novel antigens relevant to vaccine development","volume":"218","author":"Chakraborty","year":"2018","journal-title":"J Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320959696","article-title":"Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform","volume":"29","author":"Mak","year":"2020","journal-title":"Lupus"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.r120.001936","article-title":"Developments and applications of functional protein microarrays","volume":"19","author":"Syu","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.68","article-title":"IgA subclass switch recombination in human mucosal and systemic immune compartments","volume":"7","author":"Lin","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003130","article-title":"Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset","volume":"9","author":"Lindestam Arlehamn","year":"2013","journal-title":"PloS Pathog"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0008-6","article-title":"Comprehensive definition of human immunodominant CD8 antigens in tuberculosis","volume":"2","author":"Lewinsohn","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12276","article-title":"B cells and antibodies in the defense against Mycobacterium tuberculosis infection","volume":"264","author":"Achkar","year":"2015","journal-title":"Immunol Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641082","article-title":"Whole blood mycobacterial growth assays for assessing human tuberculosis susceptibility: A systematic review and meta-analysis","volume":"12","author":"Bok","year":"2021","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3329","article-title":"Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection","volume":"180","author":"Maglione","year":"2008","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/2049-632x.12069","article-title":"The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation","volume":"69","author":"Olivares","year":"2013","journal-title":"Pathog Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2005.12.004","article-title":"Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice","volume":"8","author":"Guirado","year":"2006","journal-title":"Microbes Infect"},{"key":"B71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0065-2776(07)96005-8","article-title":"Fc-receptors as regulators of immunity","volume":"96","author":"Nimmerjahn","year":"2007","journal-title":"Adv Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184373","article-title":"Identification of sero-reactive antigens for the early diagnosis of Johne\u2019s disease in cattle","volume":"12","author":"Li","year":"2017","journal-title":"PloS One"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00081-17","article-title":"Identification of novel seroreactive antigens in johne's disease cattle by using the mycobacterium tuberculosis protein array","volume":"24","author":"Bannantine","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/24206","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005770","article-title":"CD4+ T Cells Recognizing PE\/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection","volume":"12","author":"Sayes","year":"2016","journal-title":"PloS Pathog"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"Aagaard","year":"2009","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1086\/314640","article-title":"Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis","volume":"179","author":"Ravn","year":"1999","journal-title":"J Infect Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103993","article-title":"Tuberculosis vaccines in the era of Covid-19 - what is taking us so long","volume":"79","author":"Dockrell","year":"2022","journal-title":"EBioMedicine"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2147\/clep.s82389","article-title":"Tuberculosis case finding in first-degree relative contacts not living with index tuberculosis cases in Kampala, Uganda","volume":"7","author":"Chheng","year":"2015","journal-title":"Clin Epidemiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-352","article-title":"Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda","volume":"14","author":"Ma","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0027","article-title":"Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection","volume":"16","author":"Mandalakas","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: An R package for 'omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PloS Comput Biol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106111","article-title":"Redox homeostasis in Mycobacterium tuberculosis is modulated by a novel actinomycete-specific transcription factor","volume":"40","author":"Khan","year":"2021","journal-title":"EMBO J"},{"key":"B85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jim.2018.01.013","article-title":"Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1\/SIV","volume":"455","author":"Brown","year":"2018","journal-title":"J Immunol Methods"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111216","article-title":"Systems approach to define humoral correlates of immunity to Shigella","volume":"40","author":"Bernshtein","year":"2022","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:44:48Z","timestamp":1782816288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2026.1810894"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1810894","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1810894"}}